论文部分内容阅读
目的:比较头孢克腭对急性呼吸道感染的疗效和安全性。方法:选择急性呼吸道感染患者100例随机分为两组,分别给予头孢克腭及头孢拉定口服治疗。从临床及实验室检查来评价其疗效及安全性。结果:头孢克腭组临床有效率90％,细菌敏感性92％,细菌清除率89％。头孢拉定组有效率74％,细菌敏感性65％,细菌清除率69％。两组之间差异显著(P<0.05),不良反应分别为6％及8％两组之间差异不显著(P>0.05)。结论:头孢克腭治疗急性呼吸道感染临床疗效明显优于头孢拉定。
Objective: To compare the efficacy and safety of cephalo-palatal in acute respiratory infection. Methods: One hundred patients with acute respiratory infection were randomly divided into two groups, which were treated with cefacide and cefradine orally. From the clinical and laboratory tests to evaluate its efficacy and safety. Results: The clinical efficiency of Ceftik group was 90%, the sensitivity of bacteria was 92%, and the bacterial clearance rate was 89%. Cefradine effective rate of 74%, bacterial sensitivity of 65%, bacterial clearance rate of 69%. There was significant difference between the two groups (P <0.05). Adverse reactions were 6% and 8% respectively. There was no significant difference between the two groups (P> 0.05). Conclusion: Celecoxib treatment of acute respiratory infection clinical efficacy was significantly better than cefradine.